跳至主要内容
临床试验/EUCTR2021-004057-23-NL
EUCTR2021-004057-23-NL进行中(未招募)1 期

Ethanol submandibular duct ligation for drooling in children with neurodisabilities - Ethanol 2-duct ligation

Radboudumc0 个研究点目标入组 5 人开始时间: 2021年7月30日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Radboudumc
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Moderate to severe drooling indicated by Drooling Frequency Score = 3 or Drooling Severity Score = 2.
  • 2.Aged 10 years and older.
  • 3.Cerebral palsy or any other non-progressive neurodevelopmental disability.
  • 4.Contra-indications for a SMDR, or rejection towards a SMDR by patient or caregiv-ers*
  • 5.Ability and willingness to follow the study protocol and attend the 8 and 32-weeks vis-its.
  • 6.Written and informed consent from caregivers, and when appropriate, oral consent from the child.
  • * contra-indication for SMDR:
  • - posterior drooling
  • - pharyngeal dysphagia as judged by the speech and language therapist.
  • - progressive neurodisability as judged by the child neurologist.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 5
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Medical history of salivary gland abnormalities like ductal stenosis, strictures
  • 2.Previous submandibular salivary gland surgery, or other contraindications for surgery or general anesthesia.
  • 3.Recent (<6 months) glandular Botulinum Neurotoxin A (BoNT-A) injection
  • 4.Simultaneous alternative treatment for drooling.

研究者

发起方
Radboudumc

相似试验

Combining ethanol with clipping of the submandibular... | 临床试验